SecBot SecBot
8-K ·Filed Jun 18, 2026

PFE

PFIZER INC
NEUTRAL
Impact 2/10
Horizonweeks Processed5mo ago SEC0000078003-26-000085
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine CFO transition with an internal interim replacement already named, reducing near-term disruption risk. Monitor for the permanent CFO appointment announcement, which could signal strategic direction. No immediate trading catalyst from this filing alone.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$25.21
T+0 close · Jun 18, 2026 · via day close
Latest settled
+9.96%
T+60 · $27.72
Vs SPY
+8.06%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 18 $25.21entry
  2. T+1 · 5mo ago −0.52%α −0.20% · $25.08
  3. T+5 · 5mo ago −6.11%α −4.44% · $23.67
  4. T+20 · 4mo ago −0.28%α −0.81% · $25.14
  5. T+60 · 2mo ago +9.96%α +8.06% · $27.72
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Pfizer announced that CFO Dave Denton will step down effective August 15, 2026 to pursue a consumer goods opportunity, with Senior VP Cecile Guegan appointed as Interim CFO effective August 16. The company explicitly states the departure is unrelated to financial or operating results. A comprehensive internal and external search for a permanent CFO is underway.

Key Facts

  • CFO Dave Denton notified Pfizer on June 16, 2026 of his departure effective August 15, 2026 for a professional opportunity outside the pharmaceutical industry in consumer goods
  • Cecile Guegan, SVP Finance, Global Biopharmaceutical Business, named Interim CFO effective August 16, 2026
  • Departure stated as not related to the company's financial or operating results or any disagreements with accounting/reporting policies
  • Pfizer will conduct a comprehensive internal and external search for a permanent CFO successor

Financial Impact

No financial figures disclosed in this filing; CFO transition with interim appointment, no immediate financial impact

Risk Factors

  • Extended CFO vacancy could create leadership uncertainty if permanent search takes longer than expected
  • Interim CFO may lack the external investor relations experience of the departing CFO, potentially affecting communication during the next earnings call

Market Snapshot

Price
$25.44
Volume
250
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
42% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0000078003-26-000085
Document: draftcfoannouncement061726.htm0000078003-26-000085
Document: 0000078003-26-000085-index-headers.html0000078003-26-000085
Document: 0000078003-26-000085-index.html0000078003-26-000085
Document: 0000078003-26-000085.txt0000078003-26-000085

Track record

21 reports on PFE

Performance horizon

5 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +17.28% at T+60 after the Aug 4, 2026 report. 7 of 9 went positive at some point.

Filters
  1. Nov 3, 202613d ago 8-K Neutral 2/10 Entry $30.79 Now $28.86 −6.27% settles Feb 2
  2. Nov 3, 202613d ago 8-K Bullish 6/10 Entry $30.00 Now $28.86 −3.80% settles Feb 1
  3. Oct 30, 202617d ago Court Ruling Neutral 2/10 Entry $30.67 Now $28.86 −5.90% settles Jan 29
  4. Oct 23, 202624d ago Institutional Cluster Mixed 3/10 Entry $30.03 Now $28.86 −3.90% settles Jan 21
  5. Aug 13, 202613w ago Court Ruling Neutral 1/10 Entry $26.79 to $29.23 Now $28.86 +7.73% ▲ +9.11% +12.15% vs SPY
  6. Aug 12, 202613w ago Insider Buy Bullish 5/10 Entry $26.80 to $29.39 Now $28.86 +7.69% ▲ +9.66% +15.14% vs SPY
  7. Aug 12, 202613w ago Insider Cluster Bullish 6/10 Entry $26.80 to $29.39 Now $28.86 +7.69% ▲ +9.66% +15.14% vs SPY
  8. Aug 6, 202614w ago Insider Cluster Bullish 4/10 Entry $26.20 to $30.52 Now $28.86 +10.15% ▲ +16.49% +18.16% vs SPY
  9. Aug 5, 202614w ago Insider Buy Bullish 5/10 Entry $26.20 to $30.52 Now $28.86 +10.15% ▲ +16.49% +18.16% vs SPY
  10. Aug 5, 202614w ago Insider Cluster Neutral 3/10 Entry $26.20 to $30.52 Now $28.86 +10.15% ▲ +16.49% +18.16% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 18, 2026